Richard L. Greenman

2.5k total citations · 2 hit papers
22 papers, 1.9k citations indexed

About

Richard L. Greenman is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard L. Greenman has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Infectious Diseases and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard L. Greenman's work include Antimicrobial Resistance in Staphylococcus (6 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Hepatitis B Virus Studies (4 papers). Richard L. Greenman is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Hepatitis B Virus Studies (4 papers). Richard L. Greenman collaborates with scholars based in United States and Malaysia. Richard L. Greenman's co-authors include William H. Robinson, John L. Gerin, Robert H. Purcell, Paul M. Kaplan, David A. Clayton, Gordon M. Dickinson, Thomas A. Hoffman, Jack S. Remington, Roy T. Steigbigel and Michael A. Kolber and has published in prestigious journals such as JAMA, Journal of Virology and The American Journal of Medicine.

In The Last Decade

Richard L. Greenman

22 papers receiving 1.6k citations

Hit Papers

DNA Polymerase Associated with Human Hepatitis B Antigen 1973 2026 1990 2008 1973 1991 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard L. Greenman United States 12 1.3k 506 408 312 262 22 1.9k
Paul E. Hermans United States 27 1.2k 0.9× 262 0.5× 609 1.5× 664 2.1× 111 0.4× 56 2.7k
Gloria Taliani Italy 27 1.4k 1.1× 1.2k 2.4× 454 1.1× 128 0.4× 157 0.6× 124 2.4k
Uri Lopatin United States 18 1.1k 0.9× 749 1.5× 819 2.0× 328 1.1× 334 1.3× 32 2.0k
Seizaburo Kashiwagi Japan 33 2.1k 1.6× 1.1k 2.2× 411 1.0× 716 2.3× 223 0.9× 157 3.4k
Hideyuki Ikematsu Japan 36 1.9k 1.5× 604 1.2× 549 1.3× 1.4k 4.4× 524 2.0× 194 4.1k
Paul M. Kaplan United States 10 1.3k 1.0× 663 1.3× 243 0.6× 79 0.3× 262 1.0× 17 2.1k
Christa Firbas Austria 27 532 0.4× 168 0.3× 696 1.7× 348 1.1× 286 1.1× 55 1.9k
Laurel C. Preheim United States 22 687 0.5× 140 0.3× 283 0.7× 163 0.5× 124 0.5× 51 1.3k
Elina Kolho Finland 17 930 0.7× 508 1.0× 282 0.7× 71 0.2× 113 0.4× 38 1.4k
Miklos Salgo United States 22 539 0.4× 238 0.5× 2.1k 5.1× 415 1.3× 469 1.8× 53 3.2k

Countries citing papers authored by Richard L. Greenman

Since Specialization
Citations

This map shows the geographic impact of Richard L. Greenman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard L. Greenman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard L. Greenman more than expected).

Fields of papers citing papers by Richard L. Greenman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard L. Greenman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard L. Greenman. The network helps show where Richard L. Greenman may publish in the future.

Co-authorship network of co-authors of Richard L. Greenman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard L. Greenman. A scholar is included among the top collaborators of Richard L. Greenman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard L. Greenman. Richard L. Greenman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Ali S., Pierre E. Rollin, W. Gary Hlady, et al.. (1996). Hantavirus pulmonary syndrome in Florida: Association with the newly identified Black Creek Canal virus. The American Journal of Medicine. 100(1). 46–48. 69 indexed citations
2.
Greenman, Richard L.. (1992). Antibody to Endotoxin in the Treatment of Gram-negative Sepsis-Reply. JAMA. 267(17). 2326–2326. 1 indexed citations
3.
Greenman, Richard L.. (1991). A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis. JAMA. 266(8). 1097–1097. 524 indexed citations breakdown →
4.
Haskell, Lloyd, et al.. (1990). Isolated Erythroid Hypoplasia and Renal Insufficiency Induced by Long-term Griseofulvin Therapy. Southern Medical Journal. 83(11). 1327–1330. 2 indexed citations
5.
Greenman, Richard L., et al.. (1987). Toxic shock syndrome. Postgraduate Medicine. 81(4). 147–160. 7 indexed citations
6.
Greenman, Richard L., et al.. (1987). Toxic Shock Syndrome Associated with Pyomyositis Caused by a Strain of Staphylococcus aureus that Does not Produce Toxic-Shock-Syndrome Toxin-1. The Journal of Infectious Diseases. 156(3). 505–507. 25 indexed citations
7.
Dickinson, Gordon M., et al.. (1985). Successful Treatment of Gram-Negative Bacillary Meningitis With Imipenem/Cilastatin. Southern Medical Journal. 78(6). 731–732. 8 indexed citations
8.
Dickinson, Gordon M., et al.. (1985). Efficacy of imipenem/cilastatin in endocarditis. The American Journal of Medicine. 78(6). 117–121. 26 indexed citations
9.
Greenman, Richard L., et al.. (1985). Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation. Journal of Antimicrobial Chemotherapy. 15(5). 637–640. 11 indexed citations
10.
Greenman, Richard L., et al.. (1984). Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers. Antimicrobial Agents and Chemotherapy. 25(1). 16–19. 14 indexed citations
11.
Davila, Enrique, et al.. (1981). Multifocal Sporotrichosis Presenting With Lobar Pulmonary Consolidation. Southern Medical Journal. 74(6). 755–756. 2 indexed citations
12.
Dickinson, Gordon M., et al.. (1981). Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid. Antimicrobial Agents and Chemotherapy. 20(4). 481–486. 33 indexed citations
13.
Hoffman, Thomas A., et al.. (1978). Staphylococcal Endocarditis in Addicts. Southern Medical Journal. 71(6). 638–643. 22 indexed citations
14.
Greenman, Richard L., et al.. (1976). Lung biopsy in immunocompromised hosts. The American Journal of Medicine. 61(4). 584–584. 2 indexed citations
15.
Greenman, Richard L.. (1975). Coccidioidal Synovitis of the Knee. Archives of Internal Medicine. 135(4). 526–526. 11 indexed citations
16.
Steigbigel, Roy T., Richard L. Greenman, & Jack S. Remington. (1975). Antibiotic Combinations in the Treatment of Experimental Staphylococcus aureus Infection. The Journal of Infectious Diseases. 131(3). 245–251. 46 indexed citations
17.
Greenman, Richard L., et al.. (1975). A Sensitive Test for Antibody Against the Hepatitis B Core Antigen (Anti‐HBc)1. Vox Sanguinis. 29(1). 77–80. 11 indexed citations
18.
Greenman, Richard L., et al.. (1975). Lung biopsy in immunocompromised hosts. The American Journal of Medicine. 59(4). 488–496. 130 indexed citations
19.
Robinson, William H. & Richard L. Greenman. (1974). DNA Polymerase in the Core of the Human Hepatitis B Virus Candidate. Journal of Virology. 13(6). 1231–1236. 115 indexed citations
20.
Kaplan, Paul M., Richard L. Greenman, John L. Gerin, Robert H. Purcell, & William H. Robinson. (1973). DNA Polymerase Associated with Human Hepatitis B Antigen. Journal of Virology. 12(5). 995–1005. 600 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026